Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorMERRITT, Emily F
dc.contributor.authorKOCHANOWSKY, Joshua A
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorHERVÉ, Perrine
dc.contributor.authorWATSON, Alison A
dc.contributor.authorKOSHY, Anita A
dc.date.accessioned2024-11-19T13:24:00Z
dc.date.available2024-11-19T13:24:00Z
dc.date.issued2024-01-01
dc.identifier.issn1932-6203en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203356
dc.description.abstractEnToxoplasma gondii is an intracellular parasite that establishes a long-term infection in the brain of many warm-blooded hosts, including humans and rodents. Like all obligate intracellular microbes, Toxoplasma uses many effector proteins to manipulate the host cell to ensure parasite survival. While some of these effector proteins are universal to all Toxoplasma strains, some are polymorphic between Toxoplasma strains. One such polymorphic effector is GRA15. The gra15 allele carried by type II strains activates host NF-κB signaling, leading to the release of cytokines such as IL-12, TNF, and IL-1β from immune cells infected with type II parasites. Prior work also suggested that GRA15 promotes early host control of parasites in vivo, but the effect of GRA15 on parasite persistence in the brain and the peripheral immune response has not been well defined. For this reason, we sought to address this gap by generating a new IIΔgra15 strain and comparing outcomes at 3 weeks post infection between WT and IIΔgra15 infected mice. We found that the brain parasite burden and the number of macrophages/microglia and T cells in the brain did not differ between WT and IIΔgra15 infected mice. In addition, while IIΔgra15 infected mice had a lower number and frequency of splenic M1-like macrophages and frequency of PD-1+ CTLA-4+ CD4+ T cells and NK cells compared to WT infected mice, the IFN-γ+ CD4 and CD8 T cell populations were equivalent. In summary, our results suggest that in vivo GRA15 may have a subtle effect on the peripheral immune response, but this effect is not strong enough to alter brain parasite burden or parenchymal immune cell number at 3 weeks post infection.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enHumans
dc.subject.enAnimals
dc.subject.enMice
dc.subject.enToxoplasma
dc.subject.enProtozoan Proteins
dc.subject.enSignal Transduction
dc.subject.enCytokines
dc.subject.enNF-kappa B
dc.title.enToxoplasma type II effector GRA15 has limited influence in vivo.
dc.title.alternativePLoS Oneen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1371/journal.pone.0300764en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologieen_US
dc.identifier.pubmed38551902en_US
bordeaux.journalPLoS ONEen_US
bordeaux.pagee0300764en_US
bordeaux.volume19en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.issue3en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04791024
hal.version1
hal.date.transferred2024-11-19T13:24:04Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS%20ONE&rft.date=2024-01-01&rft.volume=19&rft.issue=3&rft.spage=e0300764&rft.epage=e0300764&rft.eissn=1932-6203&rft.issn=1932-6203&rft.au=MERRITT,%20Emily%20F&KOCHANOWSKY,%20Joshua%20A&HERV%C3%89,%20Perrine&WATSON,%20Alison%20A&KOSHY,%20Anita%20A&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée